Perspective
Alzheimer’s Drugs Deserve a Second Opinion
July 13, 2026
Featured Experts: Paul Aisen, MD, Joseph Grogan, JD
Research
All Research Featured Research
Journal Article
Evaluating Evidence-Based Recruitment Strategies for Alzheimer’s Disease and Related Dementias Clinical Trial Research: A Literature Review
March 16, 2026
Featured Experts: Mireille Jacobson, PhD, Desi Peneva, MS, Phyllis Barkman Ferrell, DrPH, MBA, Maria-Alice Manetas, Rema Raman, PhD, Paul Aisen, MD, Dana Goldman, PhD
News
Can We Prevent Alzheimer’s Disease Within a Decade?
March 5, 2026
Featured Experts: Paul Aisen, MD, Dana Goldman, PhD
News
USC Initiative Awards Funding to Test AI-Driven Strategies to Accelerate Alzheimer’s Clinical Trials
January 20, 2026
Featured Experts: Dana Goldman, PhD, Paul Aisen, MD
Journal Article
Recruitment and Retention in a Preclinical AD Trial: Comparisons Between Academic and Non-Academic Sites
October 14, 2025
Featured Experts: Marina Ritchie, PhD, Paul Aisen, MD, Rema Raman, PhD
Journal Article
Advancing the Science of Recruitment for Alzheimer’s Clinical Trials: Challenges and Opportunities
June 12, 2025
Featured Experts: Paul Aisen, MD, Desi Peneva, MS, Maria-Alice Manetas, Mireille Jacobson, PhD, Dana Goldman, PhD, Niranjan Bose, PhD, Phyllis Barkman Ferrell, DrPH, MBA, Rema Raman, PhD
News
Due to Complex Barriers, the Overwhelming Majority of Alzheimer’s Patients Do Not Participate in Clinical Trials
August 17, 2020
Featured Experts: Dana Goldman, PhD, Julie Zissimopoulos, PhD, Paul Aisen, MD